Correction for Su et al., "Japanese Encephalitis Virus Infection Initiates Endoplasmic Reticulum Stress and an Unfolded Protein Response" [0.03%]
苏等人的文章“日本脑炎病毒感染引发内质网应激及未折叠蛋白反应”的勘误通知
Hong-Lin Su,Ching-Len Liao,Yi-Ling Lin
Hong-Lin Su
Published Erratum
Journal of virology. 2024 Jul 23;98(7):e0040724. DOI:10.1128/jvi.00407-24 2024
Correction for Huang et al., "N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies" [0.03%]
关于黄等人文章“血凝素上的N连接聚糖和K147残基协同诱导广谱抗H1N1流感病毒的抗体”的更正
Ying Huang,Simon O Owino,Corey J Crevar et al.
Ying Huang et al.
Published Erratum
Journal of virology. 2024 Jul 23;98(7):e0112823. DOI:10.1128/jvi.01128-23 2024
Correction for Carter et al., "Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses" [0.03%]
对Carter等人的“计算优化的广泛反应性血凝素疫苗的设计与表征用于H1N1流感病毒”的更正
Donald M Carter,Christopher A Darby,Bradford C Lefoley et al.
Donald M Carter et al.
Published Erratum
Journal of virology. 2024 Jul 23;98(7):e0181323. DOI:10.1128/jvi.01813-23 2024
Retraction for Carter et al., "Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses" [0.03%]
有关Carter等人关于“在历史H1N1流感病毒预免疫的雪貂体内诱导出对抗广泛H1N1病毒的保护性抗体”的撤稿声明
Donald M Carter,Christopher A Darby,Scott K Johnson et al.
Donald M Carter et al.
Retraction of Publication
Journal of virology. 2024 Jul 23;98(7):e0183223. DOI:10.1128/jvi.01832-23 2024
Human coronavirus OC43 infection remodels connexin 43-mediated gap junction intercellular communication in vitro [0.03%]
人OC43冠状病毒感染会重塑体外连接子43介导的缝隙连接通讯
Souvik Karmakar,Jayasri Das Sarma
Souvik Karmakar
β-coronaviruses cause acute infection in the upper respiratory tract, resulting in various symptoms and clinical manifestations. OC43 is a human β-coronavirus that induces mild clinical symptoms and can be safely studied in the BSL2 labor...
Migraine inhibitor olcegepant reduces weight loss and IL-6 release in SARS-CoV-2-infected older mice with neurological signs [0.03%]
偏头痛抑制剂Olcegepant减少SARS-CoV-2感染老年小鼠的体重下降和IL-6释放作用
Shafaqat M Rahman,David W Buchholz,Brian Imbiakha et al.
Shafaqat M Rahman et al.
COVID-19 can cause neurological symptoms such as fever, dizziness, and nausea. However, such neurological symptoms of SARS-CoV-2 infection have been hardly assessed in mouse models. In this study, we infected two commonly used wild-type mou...
IDO1 promotes CSFV replication by mediating tryptophan metabolism to inhibit NF-κB signaling [0.03%]
IDO1通过介导色氨酸代谢抑制NF-κB信号促进CSFV复制
Feifan Zhao,Yaoyao Huang,Junzhi Ji et al.
Feifan Zhao et al.
Tryptophan metabolism plays a crucial role in facilitating various cellular processes essential for maintaining normal cellular function. Indoleamine 2,3-dioxygenase 1 (IDO1) catalyzes the conversion of tryptophan (Trp) into kynurenine (Kyn...
Higher HIV-1 evolutionary rate is associated with cytotoxic T lymphocyte escape mutations in infants [0.03%]
HIV-1进化率与婴儿CTL逃逸突变有关
Jamirah Nazziwa,Sophie M Andrews,Mimi M Hou et al.
Jamirah Nazziwa et al.
Escape from cytotoxic T lymphocyte (CTL) responses toward HIV-1 Gag and Nef has been associated with reduced control of HIV-1 replication in adults. However, less is known about CTL-driven immune selection in infants as longitudinal studies...
A community science approach to public health and public trust in science [0.03%]
社区科学在公共卫生与公众信任科学中的作用
Christine Marizzi,Paul Kehinde Ajayi,Rita McMahon et al.
Christine Marizzi et al.
The coronavirus disease 2019 (COVID-19) pandemic has highlighted the importance of health literacy and trust in pandemic management. Collaborating with the community to prepare for pandemics is incredibly effective in fostering understandin...
Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry [0.03%]
hexestrol，一种雌激素受体激动剂，可抑制拉沙病毒入侵
Zihan Zhang,Toru Takenaga,Sarah Katharina Fehling et al.
Zihan Zhang et al.
Lassa virus (LASV) is the causative agent of human Lassa fever which in severe cases manifests as hemorrhagic fever leading to thousands of deaths annually. However, no approved vaccines or antiviral drugs are currently available. Recently,...